CoChat

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records

Open access
Horne, Elsie M F, Hulme, William J, Keogh, Ruth H, Palmer, Tom M, Williamson, Elizabeth J, Parker, Edward P K, Green, Amelia, Walker, Venexia, Walker, Alex J, Curtis, Helen, Fisher, Louis, MacKenna, Brian, Croker, Richard, Hopcroft, Lisa, Park, Robin Y, Massey, Jon, Morley, Jessica, Mehrkar, Amir, Bacon, Sebastian, Evans, David, Inglesby, Peter, Morton, Caroline E, Hickman, George, Davy, Simon, Ward, Tom, Dillingham, Iain, Goldacre, Ben, Hernán, Miguel A, Sterne, Jonathan A C · 2022 · BMJ

Published version of a preprint

Cited by 60

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Objective: To estimate waning of covid-19 vaccine effectiveness over six months after second dose. Design: Cohort study, approved by NHS England. Setting: Linked primary care, hospital, and covid-19 records within the OpenSAFELY-TPP database. Participants: Adults without previous SARS-CoV-2 infection were eligible, excluding care home residents and healthcare professionals. Exposures: People who had received two doses of BNT162b2 or ChAdOx1 (administered during the national vaccine rollout) were compared with unvaccinated people during six consecutive comparison periods, each of four weeks. Main outcome measures: Adjusted hazard ratios for covid-19 related hospital admission, covid-19 related death, positive SARS-CoV-2 test, and non-covid-19 related death comparing vaccinated with unvaccinated people. Waning vaccine effectiveness was quantified as ratios of adjusted hazard ratios per four week period, separately for subgroups aged ≥65 years, 18-64 years and clinically vulnerable, 40-64 years, and 18-39 years. Results: 1 951 866 and 3 219 349 eligible adults received two doses of BNT162b2 and ChAdOx1, respectively, and 2 422 980 remained unvaccinated. Waning of vaccine effectiveness was estimated to be similar across outcomes and vaccine brands. In the ≥65 years subgroup, ratios of adjusted hazard ratios for covid-19 related hospital admission, covid-19 related death, and positive SARS-CoV-2 test ranged from 1.19 (95% confidence interval 1.14 to 1.24) to 1.34 (1.09 to 1.64) per four weeks. Despite waning vaccine effectiveness, rates of covid-19 related hospital admission and death were substantially lower among vaccinated than unvaccinated adults up to 26 weeks after the second dose, with estimated vaccine effectiveness ≥80% for BNT162b2, and ≥75% for ChAdOx1. By weeks 23-26, rates of positive SARS-CoV-2 test in vaccinated people were similar to or higher than in unvaccinated people (adjusted hazard ratios up to 1.72 (1.11 to 2.68) for BNT162b2 and 1.86 (1.79 to 1.93) for ChAdOx1). Conclusions: The rate at which estimated vaccine effectiveness waned was consistent for covid-19 related hospital admission, covid-19 related death, and positive SARS-CoV-2 test and was similar across subgroups defined by age and clinical vulnerability. If sustained to outcomes of infection with the omicron variant and to booster vaccination, these findings will facilitate scheduling of booster vaccination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj-2022-071249

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 9

  1. 10.1038/s41591-021-01410-w · DOI · Paper page
  2. 10.1371/journal.ppat.1010022 · DOI · Paper page
  3. 10.1016/S0140-6736(22)00089-7 · DOI · Paper page
  4. 10.1056/NEJMoa2117128 · DOI · Paper page
  5. 10.1056/NEJMoa2110362 · DOI · Paper page
  6. 10.1093/aje/kww064 · DOI · Paper page
  7. 10.1056/NEJMoa2116063 · DOI · Paper page
  8. 10.1038/s41591-022-01753-y · doi:10.1038/s41591-022-01753-y · Paper page
  9. 10.1101/2022.01.17.22269450 · DOI

Cited by

See all 60

Metadata

Authors
Horne, E. M. F., Hulme, W. J., Keogh, R. H., Palmer, T. M., Williamson, E. J., Parker, E. P. K., Green, A., Walker, V., Walker, A. J., Curtis, H., Fisher, L., MacKenna, B., Croker, R., Hopcroft, L., Park, R. Y., Massey, J., Morley, J., Mehrkar, A., Bacon, S., Evans, D., Inglesby, P., Morton, C. E., Hickman, G., Davy, S., Ward, T., Dillingham, I., Goldacre, B., Hernán, M. A., & Sterne, J. A. C.
Venue
BMJ
Publisher
BMJ
Published
2022-07-20
Volume
378
Pages
e071249
ISSN
1756-1833 (ISSN-L)
OpenAlex
W4286009783
Cited by
60
References
19
FWCI
6.46
Type
journal article
Language
en
Open access
hybrid
Funders
  • NIHR Bristol Biomedical Research Centre
  • Health Foundation
  • UK Research and Innovation
  • Medical Research Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records. https://app.cochat.ai/papers/10.1136/bmj-2022-071249
The paper
Horne, E. M. F., Hulme, W. J., Keogh, R. H., Palmer, T. M., Williamson, E. J., Parker, E. P. K., Green, A., Walker, V., Walker, A. J., Curtis, H., Fisher, L., MacKenna, B., Croker, R., Hopcroft, L., Park, R. Y., Massey, J., Morley, J., Mehrkar, A., Bacon, S., . . . Sterne, J. A. C. (2022). Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records. BMJ. https://doi.org/10.1136/bmj-2022-071249

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.